Oscar Health, Inc. (NYSE:OSCR) Insider Sells $57,532.02 in Stock

Oscar Health, Inc. (NYSE:OSCR) insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now owns 76,982 shares of the company’s stock, valued at $1,384,906.18. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Oscar Health Stock Performance

Oscar Health stock opened at $16.99 on Friday. Oscar Health, Inc. has a fifty-two week low of $4.72 and a fifty-two week high of $23.44. The company has a market capitalization of $4.03 billion, a price-to-earnings ratio of -42.48, a PEG ratio of 36.25 and a beta of 1.61. The stock has a fifty day moving average of $16.98 and a two-hundred day moving average of $17.23. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. The business had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.13 billion. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The business’s revenue for the quarter was up 44.6% compared to the same quarter last year. During the same quarter last year, the company earned ($0.07) earnings per share. On average, analysts anticipate that Oscar Health, Inc. will post 0.01 EPS for the current fiscal year.

Institutional Trading of Oscar Health

A number of hedge funds have recently bought and sold shares of the company. Avalon Trust Co acquired a new position in Oscar Health in the 1st quarter valued at $69,000. Point72 Hong Kong Ltd purchased a new stake in shares of Oscar Health in the second quarter valued at $78,000. Prevail Innovative Wealth Advisors LLC acquired a new position in Oscar Health in the fourth quarter valued at $92,000. Quest Partners LLC purchased a new position in Oscar Health during the second quarter worth about $93,000. Finally, Amalgamated Bank boosted its stake in Oscar Health by 27.7% in the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after buying an additional 1,458 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on OSCR shares. Bank of America reaffirmed a “neutral” rating and issued a $21.00 price objective (down from $25.00) on shares of Oscar Health in a research note on Thursday, May 30th. Piper Sandler upped their target price on Oscar Health from $25.00 to $28.00 and gave the company an “overweight” rating in a report on Thursday, August 8th. Baird R W raised Oscar Health to a “strong-buy” rating in a research note on Thursday, May 30th. Robert W. Baird began coverage on shares of Oscar Health in a research report on Thursday, May 30th. They issued an “outperform” rating and a $28.00 price objective on the stock. Finally, Wells Fargo & Company increased their price objective on shares of Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research note on Wednesday, June 12th. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $24.17.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.